Followers | 578 |
Posts | 58322 |
Boards Moderated | 1 |
Alias Born | 09/02/2013 |
![](https://investorshub.advfn.com/uicon/418108.png?cb=1593597758)
Tuesday, September 19, 2017 6:27:18 PM
Sep 19, 2017
OTC Disclosure & News Service
-
VICTORIA, British Columbia, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (EHT) (TSXV:EMH) (OCTQX:EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (Supreme) (TSXV:FIRE) subsidiary, 7ACRES.
“Emerald’s strategy emphasizes value-added downstream product development. Our ability to source low-cost cannabis from our own facilities is increasing through our Pure Sunfarms joint venture, which presents industry-leading scale and cost potential. Partners such as Supreme will help us supplement our supply for the higher-end dried flower segment, both for current patients and for the anticipated growth in domestic and international demand for medical and adult-use cannabis,” said Dr. Bin Huang, President and CEO of Emerald. “Supreme’s 7ACRES is a high quality grower that meets our own standards for cultivation, and which we are pleased to work with to expand our sources of dried cannabis.”
Join us on our journey of making lives better through cannabis science.
About Supreme Pharmaceuticals Inc.
Supreme Pharmaceuticals is committed to becoming a leading cultivator and distributor of sun-grown cannabis through its wholly owned subsidiary 7 Acres. 7 Acres is a federally licensed producer of medical cannabis pursuant to the ACMPR (access to cannabis for medical purposes regulations) operating inside a 342,000-square-foot hybrid greenhouse facility.
About Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) operates primarily through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary and Licensed Producer under the Access to Cannabis for Medical Purposes Regulations. Botanicals is authorized to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. Botanicals currently operates an indoor facility in Victoria, BC, and is progressing on expansion plans for a 32-acre property in Metro Vancouver and a joint venture with Village Farms utilizing a 25 acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada's most medically focused licensed producers, with a team highly experienced in life sciences product development and large-scale agribusiness. Its vision is to be a leading provider of cannabis products through its production capabilities, proprietary genetics, value-added products and branding, and superb customer experience. Emerald Health Therapeutics is part of the Emerald Health group, which comprises multiple companies advancing diverse botanical, nutraceutical and pharmaceutical products that may provide wellness and medical benefits by interacting with the body’s endocannabinoid system.
For investor and media contacts:
invest@emeraldhealth.ca
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to legalization of non-therapeutic cannabis sales in Canada; participation in the legalized non-therapeutic cannabis industry; growth in the extract-based market; increased production of cannabis; commercial operations; construction or conversion of production facilities; applications for licensing; obtaining such licenses; commencement of production of cannabis at the Company’s facilities; estimates of production capacity at such facilities; international opportunities for the Company; the Company becoming a leading Canadian supplier of cannabis products; expected timing of any of the above matters; and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Emerald Health Therapeutics Inc. does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, failure of the federal government to approve legislation legalizing sales of non-therapeutic adult-use cannabis; failure to obtain Health Canada and other regulatory approvals; failure to obtain necessary financing; availability of production facilities; timeliness of government approvals and the granting of permits and licenses; changes in prices and costs; actual operating and financial performance of facilities; equipment and processes relative to specifications and expectations; as well as the other risk factors set out in the Company’s annual information form and other filing with the applicable Canadian securities regulators, which may be viewed at www.sedar.com. Actual results may differ materially from those expressed or implied by such forward-looking statements.
My post are for entertainment only ...I do not suggest or tell people when to buy or sell..... GLTA STACKER
Recent VFF News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/09/2024 04:15:13 AM
- Pure Sunfarms Launches Grower-Led ‘Trials’ Program • GlobeNewswire Inc. • 06/27/2024 10:30:00 PM
- ROSE LifeScience announces quality upgrade to top-selling Pure Laine Big Pleasures • GlobeNewswire Inc. • 06/25/2024 11:00:00 AM
- Village Farms International to Present at iAccess Alpha Virtual Conference June 25 and 26 • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Village Farms International Reminds Shareholders to Cast Annual Meeting Votes • GlobeNewswire Inc. • 06/21/2024 11:00:00 AM
- Village Farms International Congratulates Netherlands on Cannabis Program Milestone • GlobeNewswire Inc. • 06/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:05:11 PM
- Village Farms International Amends and Extends Operating Loan • GlobeNewswire Inc. • 05/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:43:27 PM
- Village Farms International Boosts Ownership in Fast-Growing Rose LifeScience • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/22/2024 08:16:47 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:19 PM
- Village Farms International Applauds Historic Move Toward U.S. Marijuana Rescheduling • GlobeNewswire Inc. • 05/17/2024 11:00:00 AM
- Introducing Kush God: the next big strain from Pure Sunfarms • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/15/2024 08:13:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:30:16 PM
- Village Farms International Appoints Finance and Operations Veteran Carolyn Hauger to Board • GlobeNewswire Inc. • 05/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:10:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:05:29 AM
- Village Farms International Reports Strong Q1/24 Results • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Village Farms International to Report Q1/24 Results on May 8, 2024 • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- Village Farms International Expands Executive Team • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- A category innovation: Pure Sunfarms introduces Hi-Def Pre-Rolls • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM